POCO Holding (300811.SZ) plans to buy back company shares worth between 100 million to 200 million yuan.

18:37 03/08/2026

Platinum Material (300811.SZ) announced that the company plans to use its own funds or self-raised funds to repurchase a portion of its shares through a centralized bidding transaction. All repurchased shares will be canceled, and the registered capital will be correspondingly reduced. The funds for the repurchase will not be less than 100 million yuan and will not exceed 200 million yuan. The buyback price will not exceed 122.69 yuan per share.

POCO Holding (300811.SZ) announced that the company intends to use its own funds or self-raised funds to repurchase a portion of its shares through centralized bidding. The repurchased shares will be completely canceled, and the registered capital will be correspondingly reduced. The funds for the share repurchase will be no less than 100 million yuan and not exceed 200 million yuan. The repurchase price will not exceed 122.69 yuan per share.

KEEN OCEAN (08070) has issued a positive profit alert, expecting a mid-term net profit of approximately HKD 23 million, an increase of about 161.4% year-on-year.

CSPC PHARMA (01093): The Phase Ib/II clinical trial of SYS 6090 injection for the treatment of colorectal cancer has officially launched at the first research center in China.

WuXi AppTec (603259.SH) plans to launch an A-share employee stock ownership plan in 2026.

KEEN OCEAN (08070) has issued a positive profit alert, expecting a mid-term net profit of approximately HKD 23 million, an increase of about 161.4% year-on-year.

CSPC PHARMA (01093): The Phase Ib/II clinical trial of SYS 6090 injection for the treatment of colorectal cancer has officially launched at the first research center in China.

WuXi AppTec (603259.SH) plans to launch an A-share employee stock ownership plan in 2026.